Candel Therapeutics IncNASDAQ:CADL
- LAST PRICE6.7100
- TODAY'S CHANGE (%)-0.1000 (-1.4684%)
- Bid / Lots6.6000/ 2
- Ask / Lots7.0900/ 4
- Open / Previous Close6.7800 / 6.8100
- Day Range
- 52 Week Range
- Volume119,842
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CADL |
|---|---|---|
| 09:32 ET | 1977 | 6.81 |
| 09:38 ET | 500 | 6.9 |
| 09:41 ET | 300 | 6.92 |
| 09:43 ET | 200 | 6.78 |
| 09:45 ET | 100 | 6.91 |
| 09:48 ET | 688 | 7.01 |
| 09:50 ET | 490 | 7.01 |
| 09:52 ET | 100 | 7 |
| 09:54 ET | 490 | 7 |
| 09:59 ET | 590 | 7 |
| 10:01 ET | 1021 | 6.94 |
| 10:03 ET | 2529 | 6.945 |
| 10:06 ET | 1100 | 6.96 |
| 10:08 ET | 961 | 7.005 |
| 10:12 ET | 320 | 6.97 |
| 10:14 ET | 264 | 7 |
| 10:15 ET | 200 | 7 |
| 10:19 ET | 1684 | 7 |
| 10:21 ET | 947 | 6.99 |
| 10:24 ET | 490 | 6.99 |
| 10:32 ET | 500 | 7.03 |
| 10:33 ET | 569 | 6.992 |
| 10:35 ET | 400 | 6.9718 |
| 10:44 ET | 200 | 6.94 |
| 10:50 ET | 4395 | 6.895 |
| 10:51 ET | 100 | 6.91 |
| 10:55 ET | 100 | 6.98 |
| 11:00 ET | 3700 | 6.88 |
| 11:02 ET | 362 | 6.8717 |
| 11:11 ET | 111 | 6.9154 |
| 11:13 ET | 804 | 6.82 |
| 11:15 ET | 200 | 6.8352 |
| 11:24 ET | 395 | 6.84 |
| 11:27 ET | 453 | 6.83 |
| 11:29 ET | 1428 | 6.8 |
| 11:31 ET | 1345 | 6.8 |
| 11:33 ET | 100 | 6.79 |
| 11:36 ET | 5911 | 6.86 |
| 11:40 ET | 1414 | 6.7834 |
| 11:51 ET | 100 | 6.85 |
| 12:00 ET | 2247 | 6.85 |
| 12:07 ET | 866 | 6.829 |
| 12:12 ET | 146 | 6.831812 |
| 12:18 ET | 100 | 6.835 |
| 12:27 ET | 800 | 6.84 |
| 12:30 ET | 100 | 6.82 |
| 12:32 ET | 500 | 6.84 |
| 12:38 ET | 2180 | 6.8 |
| 12:41 ET | 1048 | 6.78 |
| 12:52 ET | 200 | 6.74 |
| 12:57 ET | 2907 | 6.77 |
| 12:59 ET | 2000 | 6.789 |
| 01:01 ET | 5739 | 6.85 |
| 01:06 ET | 300 | 6.815 |
| 01:10 ET | 100 | 6.83 |
| 01:15 ET | 200 | 6.82 |
| 01:17 ET | 600 | 6.77 |
| 01:19 ET | 100 | 6.78 |
| 01:21 ET | 280 | 6.8166 |
| 01:24 ET | 300 | 6.77 |
| 01:28 ET | 100 | 6.78 |
| 01:30 ET | 300 | 6.78 |
| 01:32 ET | 727 | 6.77 |
| 01:33 ET | 100 | 6.75 |
| 01:35 ET | 100 | 6.765 |
| 01:37 ET | 1100 | 6.765 |
| 01:39 ET | 1000 | 6.765 |
| 01:42 ET | 545 | 6.765 |
| 01:44 ET | 100 | 6.76 |
| 01:46 ET | 100 | 6.74 |
| 01:48 ET | 494 | 6.7151 |
| 01:50 ET | 100 | 6.7 |
| 01:51 ET | 100 | 6.72 |
| 01:53 ET | 100 | 6.7 |
| 01:55 ET | 100 | 6.7346 |
| 01:57 ET | 100 | 6.7 |
| 02:02 ET | 100 | 6.7004 |
| 02:09 ET | 512 | 6.723232 |
| 02:11 ET | 100 | 6.7409 |
| 02:13 ET | 100 | 6.724 |
| 02:15 ET | 200 | 6.75 |
| 02:20 ET | 300 | 6.73 |
| 02:22 ET | 1200 | 6.75 |
| 02:31 ET | 100 | 6.73 |
| 02:36 ET | 1055 | 6.75 |
| 02:38 ET | 144 | 6.75 |
| 02:44 ET | 764 | 6.75 |
| 02:47 ET | 200 | 6.75 |
| 02:56 ET | 100 | 6.75 |
| 03:03 ET | 356 | 6.72 |
| 03:12 ET | 758 | 6.69 |
| 03:14 ET | 400 | 6.71 |
| 03:18 ET | 400 | 6.69 |
| 03:20 ET | 500 | 6.71 |
| 03:21 ET | 400 | 6.71 |
| 03:23 ET | 4374 | 6.67 |
| 03:27 ET | 450 | 6.69 |
| 03:30 ET | 226 | 6.68 |
| 03:32 ET | 100 | 6.685 |
| 03:36 ET | 333 | 6.68 |
| 03:38 ET | 100 | 6.66 |
| 03:39 ET | 200 | 6.69 |
| 03:41 ET | 200 | 6.72 |
| 03:43 ET | 931 | 6.73 |
| 03:45 ET | 277 | 6.74 |
| 03:48 ET | 100 | 6.75 |
| 03:50 ET | 100 | 6.75 |
| 03:52 ET | 308 | 6.73 |
| 03:56 ET | 100 | 6.74 |
| 03:57 ET | 200 | 6.74 |
| 03:59 ET | 14865 | 6.71 |
Sep 4, 2024
Milestone Pharmaceuticals Appoints Industry Veteran Joseph Papa to its Board of Directors, from 8:01AM ET on Wednesday Sep 04, 2024 by Dow Jones
8:01AM ET on Wednesday Sep 04, 2024 by Dow Jones
Sep 3, 2024
Candel Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference, from 8:00AM ET on Tuesday Sep 03, 2024 by Dow Jones
8:00AM ET on Tuesday Sep 03, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Candel Therapeutics Inc | 218.5M | -3.9x | --- |
Acrivon Therapeutics Inc | 220.2M | -2.5x | --- |
Immutep Ltd | 319.9M | -8.6x | --- |
Black Diamond Therapeutics Inc | 225.2M | -2.4x | --- |
Cabaletta Bio Inc | 225.2M | -2.2x | --- |
XBiotech Inc | 228.5M | -6.1x | --- |
Company Information
Candel Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing off-the-shelf multimodal biological immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The Company has established two clinical-stage multimodal biological immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) gene constructs, respectively. CAN-2409 is the lead product candidate from the adenovirus platform and is in ongoing clinical trials in non-small cell lung cancer (NSCLC), borderline resectable pancreatic cancer, and localized, non-metastatic prostate cancer. CAN-3110 is the lead product candidate from the HSV platform and is in an ongoing investigator-sponsored phase I clinical trial in recurrent high-grade glioma (HGG). Its enLIGHTEN Discovery Platform leverages human biology and advanced analytics to create new viral immunotherapies for solid tumors.
Contact Information
- Headquarters
- 117 Kendrick Street,, Suite 450NEEDHAM, MA, United States 02494
- Phone
- 617-916-5445
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- Paul Manning
- President, Chief Executive Officer, Director
- Paul Tak
- Interim Chief Financial Officer
- Charles Schoch
- Chief Scientific Officer
- Francesca Barone
- Vice President - Development Leader
- Christopher Matheny
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $218.5M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 32.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-1.70 |
Book Value | $0.44 |
P/E Ratio | -3.9x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
